At Capsugel, we are devoted to developing capsules and other solutions to support our customers most difficult dosing challenges.
At Capsugel, we are driven by our focus on quality and have implemented numerous process quality initiatives to continuously improve the overall quality of our products.
At Capsugel, we are committed to ensuring an unmatched certainty of supply for our customers - and since you span the globe, so do we, with multiple production and business facilities worldwide.
World Class People
At Capsugel, we are focused on bringing and keeping top talent in our organization - it's our way of making sure you have the high-quality capsules you need, when and where you need them.
World Class People
At Capsugel, we are motivated by seeing our customers satisfied - so we keep your needs at the center of all our decisions to help make your job easier.
At Capsugel, we are dedicated to creating value for both our customers and their customers while always striving to provide investors with superior returns.
Capsugel to Highlight Innovative Capsule Technologies and Dosage Form Solutions at the 2014 AAPS Annual Meeting and Exposition
Morristown, N.J., October 23, 2014 – Capsugel scientists will discuss a range of advancements – including bioavailability enhancement and multiparticulate technologies, dry powder inhalation (DPI) technologies, and alternate-polymer and other specialized capsule technologies – at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, which runs November 2-6 in San Diego, Calif.
Capsugel Expands Its Lipid Multiparticulate Technology Offering
Morristown, N.J., October 7, 2014 – Capsugel announced today the broad commercial availability of its proprietary lipid multiparticulate (LMP) technology. Capsugel’s LMP technology is an innovative drug-delivery platform with multiple applications – including bioavailability enhancement, taste-masking and modified release – for both pharmaceutical and health and nutrition (H&N) products. The company’s LMP technology is based on its melt-spray congeal (MSC) processing and combines the benefits of lipid-based formulations (LBF) with the functionality of a multiparticulate dosage form in one unique offering.
Bend Research is now part of Capsugel's Dosage Form Solutions (DFS) business. Bend Research brings expertise in novel formulations, including spray-dried dispersions and hot-melt extrusion, as well as technologies in the areas of controlled-release, inhalation and bio-therapeutics. These capabilities complement Capsugel DFS’ premier capabilities in lipid and liquid formulations, modified and targeted release delivery and specialized manufacturing solutions.
Encap Drug Delivery
Based in Scotland, Encap’s focus on liquid and semi-solid encapsulation-based product development, and clinical and commercial manufacturing for the pharmaceutical industry, complements Capsugel’s recently-established Dosage Form Solutions (DFS) business unit which develops and manufactures innovative products for the healthcare industry.
Capsugel will join 8,000 scientists at the 2014 AAPS
Capsugel will join 8,000 scientists at the 2014 Annual Meeting of the American Association of Pharmaceutical Scientists scheduled for November 2-6 in San Diego, California. This is the premier meeting of scientists engaged in the discovery, development, regulation, manufacture and regulation of pharmaceutical and biological products. Capsugel will present 19 scientific posters and host 5 Expert Seminars on improving bioavailability, multiparticulate technologies, new capsule designs and applications among other topics.